Increasing incidence and prevalence of Crohn's disease is anticipated for U.S. Medical Foods Market11/13/2023 The U.S. Medical Foods Market is estimated to be valued at US$ 22,328.51 Mn in 2023 and is expected to exhibit a CAGR of 17% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:- Medical foods are used for the specific dietary management of diseases or health conditions, such as disease-specific nutritional requirements that cannot be met by normal foods. Medical foods are intended for the dietary management of a disease or condition that includes modifications to the standard diet, which is formulated to be consumed or administered under the supervision of a physician. Market Dynamics:- The major driver fueling the growth of the U.S medical foods market is the increasing incidence and prevalence of Crohn's disease. According to the Centers for Disease Control and Prevention (CDC), around 3 million people in the U.S. suffer from inflammatory bowel disease, with Crohn's disease being one of its major types. Medical foods act as dietary supplements for individuals with specific nutrient needs due to diseases like Crohn's disease. Thus, medical foods help address the specific dietary requirements of such patients. Increasing awareness regarding prebiotics and probiotic products is also expected to boost the growth of the medical foods market in the U.S. Probiotics and prebiotics help maintain the gut microbiome and provide relief from irritable bowel syndrome and Crohn's disease symptoms. Thus, the rising consumer knowledge about prebiotics and probiotics is fueling market growth. Segment Analysis:- The U.S. medical foods market is dominanted by the gastrointestinal segment which accounts for over 40% share due to the increasing prevalence of gastrointestinal disorders such as Crohn's disease and ulcerative colitis. The gastrointestinal segment is witnessing high growth owing to the rising demand for prebiotics and probiotic supplements to manage gastrointestinal conditions. PEST Analysis:-
The U.S. Medical Foods Market Demand was valued at US$ 22,328.51 million in 2023 and is expected to reach US$ 38,342.93 million by 2030, expanding at a CAGR of 17% over the forecast period. The high growth can be attributed to the increasing incidence and prevalence of gastrointestinal disorders along with rising awareness regarding prebiotics and probiotic products. Regional analysis: The Western region accounts for the largest share in the U.S. medical foods market due to the increasing incidence of chronic diseases and higher healthcare spending. The region is expected to maintain its dominance over the forecast period. Key players operating in the U.S. medical foods market are Increasing incidence and prevalence of Crohn€TMs diseaseIncreasing awareness regarding prebiotics and probiotic products. Crohn's disease and ulcerative colitis conditions are resulting in a surge in demand for specialized medical foods designed to manage gastrointestinal symptoms. Read more - https://www.newsstatix.com/u-s-medical-foods-market-size-and-trends-analysis/
0 Comments
Leave a Reply. |